Daily FNArena News - FYI

Pitt Street Research explains why Imagion Biosystems shares look undervalued.

Peter Switzer of the Switzer Super Report applies the “Buffett test” to the value of Link Administration.

Pitt Street Research finds vindication in BlackWall’s intention to spin off the Wotso flexible workspace business.

Pitt Street Research sees plenty of potential ahead for science-based neutraceutical products producer Abundant Produce.

Pitt Street Research interviewed Bob Proulx, CEO Imagion Biosystems

Peter Switzer of the Switzer Super Report examines traditional indicators of troubles ahead for equities.

Peter Switzer of the Switzer Super Report ponders whether Trump is deliberately misleading markets on trade in order to prevent a stock market collapse.

Pitt Street Research interviewed Revasum Inc CEO Jerry Cutini about the strong revenue growth opportunity on the back of the emergence of Electric Vehicles.

Pitt Street Research has initiated coverage of Revasum, confident the future offers strong growth and higher margins on a cyclical upswing.

Peter Switzer of the Switzer Super Report outlines the benefits of listed investment companies in today’s low rate world and when it’s best to buy.